scispace - formally typeset
Y

Yu Huang

Researcher at Chinese Academy of Sciences

Publications -  1798
Citations -  114451

Yu Huang is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 136, co-authored 1492 publications receiving 89209 citations. Previous affiliations of Yu Huang include The Chinese University of Hong Kong & Samsung.

Papers
More filters
Journal ArticleDOI

Endothelial cell transient receptor potential channel C5 (TRPC5) is essential for endothelium-dependent contraction in mouse carotid arteries.

TL;DR: It is demonstrated that TRPC5 in endothelial cells contributes to EDC by stimulating the production of COX‐2‐linked prostanoids.
Journal ArticleDOI

Facile synthesis of ultrathin bimetallic PtSn wavy nanowires by nanoparticle attachment as enhanced hydrogenation catalysts.

TL;DR: Owing to the ultrathin nature and unique electronic properties of these PtSn wavy nanowires, they exhibit improved catalytic performance for the hydrogenation of nitrobenzene, as well as for the Hydrogenation of styrene.
Journal ArticleDOI

Contribution of Na+ -Ca2+ exchanger to pinacidil-induced relaxation in the rat mesenteric artery.

TL;DR: Results indicate that stimulation of the forward mode Na+‐Ca2+ exchange pathway is in part responsible for pinacidil‐induced K+ channel‐independent vasorelaxation and the PKC‐mediated cellular pathway may be a target site forPinacidil only in higher concentrations.
Journal ArticleDOI

Recent progress on two-dimensional materials confining single atoms for CO2 photoreduction

TL;DR: In this article , the authors summarized the design and application, proposed challenges and opportunities, and laid a foundation for further research and application of 2D materials confining single atoms for CO2 photoreduction.
Journal ArticleDOI

Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression.

TL;DR: Results show that USP2 acts as an anti-oncogene and an independent factor for ccRCC prognosis and positive modulation of USP1 might lead to development of a novel strategy forccRCC treatment.